Genetic and transcriptional evolution alters cancer cell line drug responseUri Ben‐David, Todd R. Golub, Yosef E. Maruvka et al.|Nature|2018Cited by 943
KDM5 Histone Demethylase Activity Links Cellular Transcriptomic Heterogeneity to Therapeutic ResistanceKunihiko Hinohara, Kornélia Polyák, Hua‐Jun Wu et al.|Cancer Cell|2018Cited by 255
Intratumoral Heterogeneity: More Than Just MutationsKunihiko Hinohara, Kornélia Polyák|Trends in Cell Biology|2019Cited by 229
Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast CancerShaokun Shu, Kornélia Polyák, Hua‐Jun Wu et al.|Molecular Cell|2020Cited by 207
Perturbed myoepithelial cell differentiation in BRCA mutation carriers and in ductal carcinoma in situLina Ding, Kornélia Polyák, Ying Su et al.|Nature Communications|2019Cited by 54